Matthew L. Sherman, EVP & Chief Medical Officer at ACCELERON PHARMA INC (XLRN), sold 18,400 shares at $38.32 ($707K) on 2017-09-12, disclosed to the SEC on 2017-09-14.
Open-market sale of $707k XLRN by EVP & Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.32 | 16,650 | $638K | 90.3% |
| 2 | $39.24 | 1,600 | $63K | 8.9% |
| 3 | $39.91 | 150 | $6K | 0.8% |
| Total | $38.41 avg | 18,400 | $707K | 100% |
| Filing → |
| DCPH | SELL | 2023-12-14 | $43K | — | Filing → |
| DCPH | SELL | 2023-10-31 | $28K | — | Filing → |
| DCPH | SELL | 2023-10-04 | $37K | — | Filing → |